ESC 365 - The beneficial effects of sodium glucose co-transporter-2 inhibitor in type 2 diabetes patients with multiple risk factors needs to be explored further: a meta-analysis

EAPC Premium Access

The beneficial effects of sodium glucose co-transporter-2 inhibitor in type 2 diabetes patients with multiple risk factors needs to be explored further: a meta-analysis

Session: Moderated ePoster 31

Topic: Cardiovascular Disease in Special Populations, Other

Speaker: Professor S. Ghosal (Kolkata, IN)

Event: ESC Preventive Cardiology 2023

Congress Presentation

Add to my library

About the speaker

Professor Samit Ghosal

Nightingale Hospital, Kolkata (India)

0 follower

5 more presentations in this session

The effects of cardiovascular rehabilitation in patients with coronary artery disease with or without diabetes assessed by thoracic bioimpedance - do they benefit equally?

Speaker: Doctor M. Stojanovic (Niska Banja, RS)

Associations between exercise training characteristics and change in peak oxygen consumption in patients with chronic ischaemic heart disease and type 2 diabetes

Speaker: Mr F. Gass (Munich, DE)

Trends in diabetes mellitus among hospital hospitalizations in Switzerland

Speaker: Professor P. Marques-Vidal (Lausanne, CH)

Prevention of metabolic syndrome implies prevention of severe and multivessel coronary artery disease.

Speaker: Doctor I. Vogiatzis (Veria, GR)

Cardiac pre-participation evaluation in adolescent male basketball athletes in Brazil

Speaker: Doctor C. Colombo (Campinas, BR)

Access the full session

Moderated ePoster 31

Speakers: Professor S. Ghosal, Doctor M. Stojanovic, Mr F. Gass, Professor P. Marques-Vidal, Doctor I. Vogiatzis...

About the event

ESC Preventive Cardiology 2023

13 April - 15 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources